-
9
-
-
84860159933
-
-
P. P. Deshpande J. Singh A. Pullockaran T. Kissick B. A. Ellsworth J. Z. Gougoutas J. Dimarco M. Fakes M. Reyes C. Lai H. Lobinger T. Denzel P. Ermann G. Crispino M. Randazzo Z. Gao R. Randazzo M. Lindrud V. Rosso F. Buono W. W. Doubleday S. Leung P. Richberg D. Hughes W. N. Washburn W. Meng K. J. Volk R. H. Mueller Org. Process Res. Dev. 2012 16 577 585
-
(2012)
Org. Process Res. Dev.
, vol.16
, pp. 577-585
-
-
Deshpande, P.P.1
Singh, J.2
Pullockaran, A.3
Kissick, T.4
Ellsworth, B.A.5
Gougoutas, J.Z.6
Dimarco, J.7
Fakes, M.8
Reyes, M.9
Lai, C.10
Lobinger, H.11
Denzel, T.12
Ermann, P.13
Crispino, G.14
Randazzo, M.15
Gao, Z.16
Randazzo, R.17
Lindrud, M.18
Rosso, V.19
Buono, F.20
Doubleday, W.W.21
Leung, S.22
Richberg, P.23
Hughes, D.24
Washburn, W.N.25
Meng, W.26
Volk, K.J.27
Mueller, R.H.28
more..
-
11
-
-
84888416796
-
-
M. Zegarac E. Leksic P. Sket J. Plavec M. D. Bogdanovic D.-K. Bučar M. Dumic E. Mestrovic CrystEngComm 2012 16 32 35
-
(2012)
CrystEngComm
, vol.16
, pp. 32-35
-
-
Zegarac, M.1
Leksic, E.2
Sket, P.3
Plavec, J.4
Bogdanovic, M.D.5
Bučar, D.-K.6
Dumic, M.7
Mestrovic, E.8
-
15
-
-
84902517547
-
-
2008002824
-
J. Z. Gougoutas, H. Lobinger, S. Ramakrishnan, P. P. Deshpande, J. T. Bien, C. Lai, C. Wang, P. Riebel, J. A. Grosso, A. A. Nirschl, J. Singh and J. D. Dimarco, WO Pat., 2008002824, 2008
-
(2008)
WO Pat.
-
-
Gougoutas, J.Z.1
Lobinger, H.2
Ramakrishnan, S.3
Deshpande, P.P.4
Bien, J.T.5
Lai, C.6
Wang, C.7
Riebel, P.8
Grosso, J.A.9
Nirschl, A.A.10
Singh, J.11
Dimarco, J.D.12
-
16
-
-
84902487573
-
Food and Drug Administration
-
Food and Drug Administration, FDA approves Farxiga to treat type 2 diabetes, 2014, http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ ucm380829.htm
-
(2014)
FDA Approves Farxiga to Treat Type 2 Diabetes
-
-
-
18
-
-
56349133989
-
-
M. B. J. Atkinson D.-K. Bučar A. N. Sokolov T. FriŠčić C. N. Robinson M. Y. Bilal N. G. Sinada A. Chevannes L. R. MacGillivray Chem. Commun. 2008 5713 5715
-
(2008)
Chem. Commun.
, pp. 5713-5715
-
-
Atkinson, M.B.J.1
Bučar, D.-K.2
Sokolov, A.N.3
Frišč ić, T.4
Robinson, C.N.5
Bilal, M.Y.6
Sinada, N.G.7
Chevannes, A.8
Macgillivray, L.R.9
-
49
-
-
40849136136
-
-
C. F. Macrae I. J. Bruno J. A. Chisholm P. R. Edgington P. McCabe E. Pidcock L. Rodriguez-Monge R. Taylor J. van de Streek P. A. Wood J. Appl. Crystallogr. 2008 41 466 470
-
(2008)
J. Appl. Crystallogr.
, vol.41
, pp. 466-470
-
-
Macrae, C.F.1
Bruno, I.J.2
Chisholm, J.A.3
Edgington, P.R.4
McCabe, P.5
Pidcock, E.6
Rodriguez-Monge, L.7
Taylor, R.8
Van De Streek, J.9
Wood, P.A.10
-
51
-
-
0000016277
-
-
I. J. Bruno J. C. Cole P. R. Edgington M. Kessler C. F. Macrae P. McCabe J. Pearson R. Taylor Acta Crystallogr., Sect. B: Struct. Sci. 2002 58 389 397
-
(2002)
Acta Crystallogr., Sect. B: Struct. Sci.
, vol.58
, pp. 389-397
-
-
Bruno, I.J.1
Cole, J.C.2
Edgington, P.R.3
Kessler, M.4
Macrae, C.F.5
McCabe, P.6
Pearson, J.7
Taylor, R.8
-
56
-
-
77954488616
-
-
Explanatory variables utilised in the HBP methodology include the identity of the functional groups, donor/acceptor competition, steric hindrance and the aromaticity of the molecules.
-
P. T. A. Galek L. Fábián F. H. Allen CrystEngComm 2010 12 2091 2099
-
(2010)
CrystEngComm
, vol.12
, pp. 2091-2099
-
-
Galek, P.T.A.1
Fábián, L.2
Allen, F.H.3
-
57
-
-
0036884338
-
-
I. D. H. Oswald D. R. Allan P. A. McGregor W. D. S. Motherwell S. Parsons C. R. Pulham Acta Crystallogr., Sect. B: Struct. Sci. 2002 58 1057 1066
-
(2002)
Acta Crystallogr., Sect. B: Struct. Sci.
, vol.58
, pp. 1057-1066
-
-
Oswald, I.D.H.1
Allan, D.R.2
McGregor, P.A.3
Motherwell, W.D.S.4
Parsons, S.5
Pulham, C.R.6
-
62
-
-
84886847457
-
-
D.-K. Bučar G. M. Day I. Halasz G. G. Z. Zhang J. R. G. Sander D. G. Reid L. R. MacGillivray M. J. Duer W. Jones Chem. Sci. 2013 4 4417 4425
-
(2013)
Chem. Sci.
, vol.4
, pp. 4417-4425
-
-
Bučar, D.-K.1
Day, G.M.2
Halasz, I.3
Zhang, G.G.Z.4
Sander, J.R.G.5
Reid, D.G.6
Macgillivray, L.R.7
Duer, M.J.8
Jones, W.9
|